SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-165896
Filing Date
2017-05-10
Accepted
2017-05-10 16:17:03
Documents
3
Period of Report
2017-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d560840d8k.htm 8-K 12334
2 EX-99.1 d560840dex991.htm EX-99.1 37559
3 GRAPHIC g560840g45v45.jpg GRAPHIC 6151
  Complete submission text file 0001193125-17-165896.txt   59789
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 17830479
SIC: 2836 Biological Products, (No Diagnostic Substances)